Finance

Lists
4569:TYO
Kyorin Pharmaceutical Co Ltd
1 098,00 JP¥
0,00%
(0,00) 1D
1-окт., 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4569...
Mkt. cap
65,82 млд
Avg. vol.
263,11 миң
Volume
0,00
Dividend
5,19%
Quarterly dividend
14 JP¥
Ex-dividend date
2026-ж., 29-сен.
P/E ratio
29,04
52-wk high
1 725 JP¥
52-wk low
1 052 JP¥
EPS
38 JP¥
Shares outstanding
63,52 млн
No. of employees
2 миң
Mkt. cap
65,82 млд
Avg. vol.
263,11 миң
Volume
0,00
Dividend
5,19%
Quarterly dividend
14 JP¥
Ex-dividend date
2026-ж., 29-сен.
P/E ratio
29,04
52-wk high
1 725 JP¥
52-wk low
1 052 JP¥
EPS
38 JP¥
Shares outstanding
63,52 млн
No. of employees
2 миң
News stories
From web sources and news partners
About Kyorin Pharmaceutical Co Ltd
CEO-
Employees1,98 миң
Founded1923
Headquarters-
SectorPharmaceutical industry
Last report
2026-ж., 30-июл.
Fiscal period
Q1 2027
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
29,65 млд / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
28,50 млд
33,72 млд
33,80 млд
29,65 млд
Cost of goods sold
16,87 млд
19,09 млд
21,71 млд
17,48 млд
Cost of revenue
16,87 млд
19,09 млд
21,71 млд
17,48 млд
Research and development expenses
-
-
12,06 млд
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12,64 млд
11,39 млд
1,07 млд
11,21 млд
Operating expense
12,69 млд
11,39 млд
13,13 млд
11,22 млд
Total operating expenses
29,56 млд
30,48 млд
34,84 млд
28,69 млд
Operating income
-1,06 млд
3,24 млд
-1,04 млд
964,00 млн
Other non operating income
11,00 млн
12,00 млн
13,00 млн
15,00 млн
EBT including unusual items
-699,00 млн
3,49 млд
-1,07 млд
1,19 млд
EBT excluding unusual items
-1,04 млд
3,51 млд
-1,07 млд
1,24 млд
Income tax expense
-93,00 млн
869,00 млн
-402,00 млн
363,00 млн
Effective tax rate
13,30%
24,87%
37,47%
30,58%
Other operating expenses
-
-
-
-
Net income
-606,00 млн
2,62 млд
-671,00 млн
824,00 млн
Net profit margin
-2,13%
7,78%
-1,99%
2,78%
Earnings per share
-
-
-
-
Interest and investment income
38,00 млн
235,00 млн
12,00 млн
288,00 млн
Interest expense
-61,00 млн
-59,00 млн
-70,00 млн
-59,00 млн
Net interest expenses
-23,00 млн
176,00 млн
-58,00 млн
229,00 млн
Depreciation and amortization charges
3,00 млн
3,00 млн
2,00 млн
2,00 млн
EBITDA
82,00 млн
4,39 млд
121,75 млн
2,13 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору